Jacques R. Caldwell

Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events

Kenneth G. Saag, Rochelle Koehnke, Jacques R. Caldwell et al. · The American Journal of Medicine · 1994 · 535 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial

Claire Bombardier, James Ware, I. Jon Russell et al. · The American Journal of Medicine · 1986 · 362 citations

Medicine, Internal Medicine, Pharmacotherapy +6

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate

Stanley Cohen, Grant W. Cannon, Michael Schiff et al. · Arthritis & Rheumatism · 2001 · 298 citations

Medicine, Pharmacology, Pharmacotherapy +10

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

Grant W. Cannon, Jacques R. Caldwell, Peter R. Holt et al. · Arthritis & Rheumatism · 2000 · 279 citations

Medicine, Pharmacology, Pharmacotherapy +15

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

Tino Münster, John P. Gibbs, Danny D. Shen et al. · Arthritis & Rheumatism · 2002 · 249 citations

Medicine, Pharmacology, Pharmacotherapy +10